Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Medical
- Device
- Diagnostic
- Personal Care Products
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 3322
License Grant
The Licensee has an oral arrangement with the Russian Licensor, providing for a royalty on all sales of the Lasette.
License Property
The Lasette has received clearance from the FDA for drawing capillary blood samples and for capillary blood sampling for all clinical screening tests. The Lasette is an alternative to the steel lancet or needle that has been approved by the FDA that allows diabetics to sample their blood for glucose testing so they can determine their subsequent insulin injections.
The Lasette is a compact, lightweight, portable crystal laser that utilizes laser light to vaporize a small hole in the finger for capillary blood sampling. At nine ounces, the Lasette is slightly larger than a handheld cellular telephone and it fits into a suit-coat pocket or a purse. The Lasette is a better alternative for capillary blood sampling for many diabetics because, for many patients, it causes less pain and residual soreness than the traditional steel lancet. The Lasette may be a better alternative for children with diabetes, newly diagnosed diabetics and needle-phobic or needle-adverse individuals.
Field of Use
The Licensee is a medical products company that develops, sells, and markets technological devices.
IPSCIO Record ID: 1986
License Grant
The Company has licensed perforation know-how in the production of a compact, low-cost laser design utilized in the Lasette(-TM-).
License Property
The Lasette(-TM-is a compact, lightweight, portable skin perforator, designed to permit nearly painless sampling of capillary blood in both clinical and home settings for the purpose of subsequent glucose or all other screening tests.
The Lasette(-TM-) product was originally developed using the multifaceted crystal resonator patent technology acquired by the Company.
IPSCIO Record ID: 25985
License Grant
Licensor grants to Licensee an exclusive, worldwide right to distribute, market and sell the Lasette I and Lasette II products for human applications for the blood sampling for glucose testing market.
License Property
Licensor has developed a first generation laser finger perforator device known as the Lasette I, and intends to develop with Licensee a second generation laser finger perforator device known as the Lasette II.
The term Lasette II shall be used generally to mean the laser finger perforator device intended for human use, to be utilized by consumers in non-clinical settings, and designed and constructed to incorporate and exploit the patents, know-how, and engineering technologies more specifically defined.
The terms Lasette I Disposable Lens Shield and Lasette II Disposable Lens Shield (sometimes collectively referred to as Lasette Disposables) shall mean devices designed and constructed to protect the Lasette unit laser lenses from vapor and particulate caused as a by-product of the laser finger perforation, incorporating and exploiting the patents, know- how, and engineering technologies more specifically defined.
Field of Use
The rights granted apply for human applications for the blood sampling for glucose testing market.
IPSCIO Record ID: 29387
License Grant
Licensor hereby grants to Licensee an exclusive, sublicense to import, make, have made for its own use and sale, use, offer to sell, offered to sell, sold and sell Product covered by a Valid Claim of the Licensed Patent in the United States of America, without the right to grant sublicenses.
License Property
Patent No. 5,165,418 – A laser and method for punching tiny holes in human skin for the purpose of taking blood samples.
The taking of blood samples is a very important part of the process of diagnosing and controlling disease. The traditional method used for taking small blood samples for blood formula and glucose measurement is to puncture the skin of a finger with a sharp object like a needle or pointed blade. For the taking of larger samples for other blood analysis a vein is usually punctured with a syringe needle. These methods are almost always painful and frightening, especially for children. In addition there is growing concern regarding the possibility of contracting AIDS by a contaminated needle or blade.
Field of Use
'LICENSED FIELD' as used herein and is limited to the practice of the LICENSED PATENT for laser devices for human capillary sampling and all related accessory products.
IPSCIO Record ID: 2288
License Grant
Licensee, the company subsidiary, entered into an agreement that permits licensee to use Sensor technology (Noninvasive Glucose Sensor) for the manufacture and sale by licensee of a proposed implantable closed loop system.
License Property
The Sensor will enable users to measure blood glucose levels without taking blood samples. The Sensor is subject to clinical testing and regulatory approvals by the FDA.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
